These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25598718)

  • 21. Fecal microbiota transplant in patients with Clostridium difficile infection: A systematic review.
    Chapman BC; Moore HB; Overbey DM; Morton AP; Harnke B; Gerich ME; Vogel JD
    J Trauma Acute Care Surg; 2016 Oct; 81(4):756-64. PubMed ID: 27648772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Faecal Microbiota Transplantation is Effective for the Initial Treatment of Clostridium difficile Infection: A Retrospective Clinical Review.
    Roshan N; Clancy AK; Borody TJ
    Infect Dis Ther; 2020 Dec; 9(4):935-942. PubMed ID: 32979161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Faecal microbiota transplantation for recurrent Clostridioides difficile infection: experience with lyophilized oral capsules.
    Reigadas E; Bouza E; Olmedo M; Vázquez-Cuesta S; Villar-Gómara L; Alcalá L; Marín M; Rodríguez-Fernández S; Valerio M; Muñoz P
    J Hosp Infect; 2020 Jun; 105(2):319-324. PubMed ID: 31883938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complications, effectiveness, and long term follow-up of fecal microbiota transfer by nasoduodenal tube for treatment of recurrent
    van Beurden YH; de Groot PF; van Nood E; Nieuwdorp M; Keller JJ; Goorhuis A
    United European Gastroenterol J; 2017 Oct; 5(6):868-879. PubMed ID: 29026601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fecal microbiota transplantation for the treatment of Clostridium difficile infection.
    Rao K; Safdar N
    J Hosp Med; 2016 Jan; 11(1):56-61. PubMed ID: 26344412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal microbiota transplantation for recurrent
    Nanki K; Mizuno S; Matsuoka K; Ono K; Sugimoto S; Kiyohara H; Arai M; Nakashima M; Takeshita K; Saigusa K; Senoh M; Fukuda T; Naganuma M; Kato H; Suda W; Hattori M; Kanai T
    Intest Res; 2018 Jan; 16(1):142-146. PubMed ID: 29422809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fecal Microbiota Transplantation for Clostridium difficile Infection: A Systematic Review.
    Drekonja D; Reich J; Gezahegn S; Greer N; Shaukat A; MacDonald R; Rutks I; Wilt TJ
    Ann Intern Med; 2015 May; 162(9):630-8. PubMed ID: 25938992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment approaches including fecal microbiota transplantation for recurrent Clostridium difficile infection (RCDI) among infectious disease physicians.
    Bakken JS; Polgreen PM; Beekmann SE; Riedo FX; Streit JA
    Anaerobe; 2013 Dec; 24():20-4. PubMed ID: 24012687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of, and patient satisfaction with, colonoscopic-administered fecal microbiota transplantation in relapsing and refractory community- and hospital-acquired Clostridium difficile infection.
    Khan MA; Sofi AA; Ahmad U; Alaradi O; Khan AR; Hammad T; Pratt J; Sodeman T; Sodeman W; Kamal S; Nawras A
    Can J Gastroenterol Hepatol; 2014 Sep; 28(8):434-8. PubMed ID: 25014180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and Efficacy of Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in Patients With Cancer Treated With Cytotoxic Chemotherapy: A Single-Institution Retrospective Case Series.
    Hefazi M; Patnaik MM; Hogan WJ; Litzow MR; Pardi DS; Khanna S
    Mayo Clin Proc; 2017 Nov; 92(11):1617-1624. PubMed ID: 29101931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
    Khoruts A; Rank KM; Newman KM; Viskocil K; Vaughn BP; Hamilton MJ; Sadowsky MJ
    Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1433-8. PubMed ID: 26905904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of Clostridium difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant: Should We Recommend Anti-Clostridium difficile Antibiotic Prophylaxis?
    Allegretti JR; Kao D; Phelps E; Roach B; Smith J; Ganapini VC; Kassam Z; Xu H; Fischer M
    Dig Dis Sci; 2019 Jun; 64(6):1668-1671. PubMed ID: 30632052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study.
    Orenstein R; Dubberke E; Hardi R; Ray A; Mullane K; Pardi DS; Ramesh MS;
    Clin Infect Dis; 2016 Mar; 62(5):596-602. PubMed ID: 26565008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Retrospective Comparison of Fecal Microbial Transplantation Methods for Recurrent Clostridium Difficile Infection.
    Cohen NA; Livovsky DM; Yaakobovitch S; Ben Yehoyada M; Ben Ami R; Adler A; Guzner-Gur H; Goldin E; Santo ME; Halpern Z; Paz K; Maharshak N
    Isr Med Assoc J; 2016 Oct; 18(10):594-599. PubMed ID: 28471618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early Results of Fecal Microbial Transplantation Protocol Implementation at a Community-based University Hospital.
    Duarte-Chavez R; Wojda TR; Zanders TB; Geme B; Fioravanti G; Stawicki SP
    J Glob Infect Dis; 2018; 10(2):47-57. PubMed ID: 29910564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fecal microbiome transplantation for recurrent Clostridium difficile infection: report on a case series.
    Rubin TA; Gessert CE; Aas J; Bakken JS
    Anaerobe; 2013 Feb; 19():22-6. PubMed ID: 23182843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection.
    Youngster I; Russell GH; Pindar C; Ziv-Baran T; Sauk J; Hohmann EL
    JAMA; 2014 Nov; 312(17):1772-8. PubMed ID: 25322359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbiome changes associated with sustained eradication of Clostridium difficile after single faecal microbiota transplantation in children with and without inflammatory bowel disease.
    Hourigan SK; Chen LA; Grigoryan Z; Laroche G; Weidner M; Sears CL; Oliva-Hemker M
    Aliment Pharmacol Ther; 2015 Sep; 42(6):741-52. PubMed ID: 26198180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of the implementation of a multidisciplinary programme of faecal microbiota transplantation by colonoscopy for the treatment of recurrent Clostridium difficile infection.
    López-Sanromán A; Rodríguez de Santiago E; Cobo Reinoso J; Del Campo Moreno R; Foruny Olcina JR; García Fernández S; García García de Paredes A; Aguilera Castro L; Ferre Aracil C; Albillos Martínez A
    Gastroenterol Hepatol; 2017 Nov; 40(9):605-614. PubMed ID: 28433406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Intragastric Fecal Microbiota Transplantation Program for Treatment of Recurrent Clostridium difficile in Children is Efficacious, Safe, and Inexpensive.
    Brumbaugh DE; De Zoeten EF; Pyo-Twist A; Fidanza S; Hughes S; Dolan SA; Child J; Dominguez SR
    J Pediatr; 2018 Mar; 194():123-127.e1. PubMed ID: 29198534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.